Back
Veraxa Biotech Holding AG VRXA · Insights
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treat... Price1.01
Market Cap144.71 M
Float39.35 M
CountryDE
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro